UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Outcomes of patients with chronic renal insufficiency in the Bypass Angioplasty Revascularization Investigation

Circulation (New York, N.Y.), 2002-05, Vol.105 (19), p.2253-2258

2002

Volltextzugriff (PDF)

Effect of Nesiritide in Patients with Acute Decompensated Heart Failure

The New England journal of medicine, 2011-07, Vol.365 (1), p.32-43

2011

Volltextzugriff (PDF)

Population pharmacokinetics and pharmacodynamics of rivaroxaban in patients with non-valvular atrial fibrillation: Results from ROCKET AF

Journal of clinical pharmacology, 2014-08, Vol.54 (8), p.917-927

2014

Volltextzugriff (PDF)

P3622Timing of trial stoppage for non-inferiority trials and interpretation: lessons from ROCKET AF

European heart journal, 2017-08, Vol.38 (suppl_1)

2017

Volltextzugriff (PDF)

Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes. Findings from the GUSTO-IIb Study

European heart journal, 2000-11, Vol.21 (21), p.1750-1758

2000

Volltextzugriff (PDF)

Incidence and predictors of bleeding events after fibrinolytic therapy with fibrin-specific agents. A comparison of TNK-tPA and rt-PA

European heart journal, 2001-12, Vol.22 (24), p.2253-2261

2001

Volltextzugriff (PDF)

Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes

European heart journal, 2004-02, Vol.25 (4), p.313-321

2004

Volltextzugriff (PDF)

Minimal myocardial damage during coronary intervention is associated with impaired outcome

European heart journal, 1999-08, Vol.20 (15), p.1112-1119

1999

Volltextzugriff (PDF)

Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry

European heart journal, 1999-08, Vol.20 (16), p.1182-1190

1999

Volltextzugriff (PDF)

Time-based risk assessment after myocardial infarction. Implications for timing of discharge and applications to medical decision-making

European heart journal, 2003-01, Vol.24 (2), p.182-189

2003

Volltextzugriff (PDF)

Lack of progress in cardiogenic shock: lessons from the GUSTO trials

European heart journal, 2000-12, Vol.21 (23), p.1928-1936

2000

Volltextzugriff (PDF)

Predictors of 90-day outcome in patients stabilized after acute coronary syndromes

European heart journal, 2003-01, Vol.24 (2), p.172-181

2003

Volltextzugriff (PDF)

Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes. Results from PURSUIT

European heart journal, 2000-03, Vol.21 (5), p.371-381

2000

Volltextzugriff (PDF)

Restenosis: The cost to society

The American heart journal, 1995-09, Vol.130 (3), p.680-684

Califf, Robert M.

1995

Volltextzugriff (PDF)

Frequency and clinical outcome of cardiogenic shock during acute myocardial infarction among patients receiving reteplase or alteplase. Results from GUSTO-III

European heart journal, 1999-01, Vol.20 (2), p.128-135

1999

Volltextzugriff (PDF)

Patients with acute coronary syndromes without persistent ST elevation undergoing percutaneous coronary intervention benefit most from early intervention with protection by a glycoprotein IIb/IIIa receptor blocker

European heart journal, 2002-02, Vol.23 (3), p.239-246

2002

Volltextzugriff (PDF)

Does the discharge ECG provide additional prognostic insight(s) in non-ST elevation ACS patients from that acquired on admission?

European heart journal, 2003-03, Vol.24 (6), p.522-531

2003

Volltextzugriff (PDF)

Patients with Evolving Myocardial Infarction Have a Significant Missed Opportunity for Earlier Treatment: Experience from the SYNERGY Trial

Annals of emergency medicine, 2005-09, Vol.46 (3), p.3-3

2005

Volltextzugriff (PDF)

The ESCAPE Discharge Risk Score: Don't Go Home without It

Journal of cardiac failure, 2006-08, Vol.12 (6), p.S117-S117

2006

Volltextzugriff (PDF)

Who is at risk of early Hypotension and renal dysfunction with an inhibitor of the Renin Angiotensin System after myocardial infarction? data from VALIANT

Journal of cardiac failure, 2004-08, Vol.10 (4), p.S89-S90

2004

Volltextzugriff (PDF)

Do sudden cardiac death rates warrant earlier treatment following myocardial infarction? experience from the VALIANT Trial

Journal of cardiac failure, 2004-08, Vol.10 (4), p.S71-S71

2004

Volltextzugriff (PDF)

Is the combination of valsartan and captopril better than captopril alone in patients with heart failure and left ventricular systolic dysfunction after myocardial infarction? results of VALIANT

Journal of cardiac failure, 2004-08, Vol.10 (4), p.S76-S76

2004

Volltextzugriff (PDF)

Does eptifibatide confer a greater benefit to patients with unstable angina than with non-ST segment elevation myocardial infarction?. Insights from the PURSUIT Trial

European heart journal, 2002-07, Vol.23 (14), p.1102-1111

2002

Volltextzugriff (PDF)

Can the Risk of Sudden Death after myocardial infarction be predicted by simple clinical criteria? experience from the VALIANT trial

Journal of cardiac failure, 2004-08, Vol.10 (4), p.S22-S22

2004

Volltextzugriff (PDF)

Patterns and outcomes of revascularization in patients with heart failure and/or left ventricular systolic dysfunction following acute myocardial infarction: observations from the VALIANT registry

Journal of cardiac failure, 2004-08, Vol.10 (4), p.S104-S104

2004

Volltextzugriff (PDF)

1 – 25 von 61

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(58)

Publikationsform

Artikel
(58)
Tagungsberichte
(3)

Sprache

Englisch
(61)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Outcomes of patients with chronic renal insufficiency in the Bypass Angioplasty Revascularization Investigation

Effect of Nesiritide in Patients with Acute Decompensated Heart Failure

Population pharmacokinetics and pharmacodynamics of rivaroxaban in patients with non-valvular atrial fibrillation: Results from ROCKET AF

P3622Timing of trial stoppage for non-inferiority trials and interpretation: lessons from ROCKET AF

Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes. Findings from the GUSTO-IIb Study

Incidence and predictors of bleeding events after fibrinolytic therapy with fibrin-specific agents. A comparison of TNK-tPA and rt-PA

Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes

Minimal myocardial damage during coronary intervention is associated with impaired outcome

Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry

Time-based risk assessment after myocardial infarction. Implications for timing of discharge and applications to medical decision-making

Lack of progress in cardiogenic shock: lessons from the GUSTO trials

Predictors of 90-day outcome in patients stabilized after acute coronary syndromes

Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes. Results from PURSUIT

Restenosis: The cost to society

Frequency and clinical outcome of cardiogenic shock during acute myocardial infarction among patients receiving reteplase or alteplase. Results from GUSTO-III

Patients with acute coronary syndromes without persistent ST elevation undergoing percutaneous coronary intervention benefit most from early intervention with protection by a glycoprotein IIb/IIIa receptor blocker

Does the discharge ECG provide additional prognostic insight(s) in non-ST elevation ACS patients from that acquired on admission?

Patients with Evolving Myocardial Infarction Have a Significant Missed Opportunity for Earlier Treatment: Experience from the SYNERGY Trial

The ESCAPE Discharge Risk Score: Don't Go Home without It

Who is at risk of early Hypotension and renal dysfunction with an inhibitor of the Renin Angiotensin System after myocardial infarction? data from VALIANT

Do sudden cardiac death rates warrant earlier treatment following myocardial infarction? experience from the VALIANT Trial

Is the combination of valsartan and captopril better than captopril alone in patients with heart failure and left ventricular systolic dysfunction after myocardial infarction? results of VALIANT

Does eptifibatide confer a greater benefit to patients with unstable angina than with non-ST segment elevation myocardial infarction?. Insights from the PURSUIT Trial

Can the Risk of Sudden Death after myocardial infarction be predicted by simple clinical criteria? experience from the VALIANT trial

Patterns and outcomes of revascularization in patients with heart failure and/or left ventricular systolic dysfunction following acute myocardial infarction: observations from the VALIANT registry

Suchergebnisse filtern